Follow
Saul Navarro
Saul Navarro
Departamento de Física Aplicada, Universidad de Granada
Verified email at ugr.es
Title
Cited by
Cited by
Year
Cancer suicide gene therapy: a patent review
SA Navarro, E Carrillo, C Grinan-Lison, A Martin, M Peran, JA Marchal, ...
Expert opinion on therapeutic patents 26 (9), 1095-1104, 2016
552016
5-Fluorouracil derivatives: a patent review (2012–2014)
E Carrillo, SA Navarro, A Ramírez, MÁ García, C Griñán-Lisón, M Perán, ...
Expert opinion on therapeutic patents 25 (10), 1131-1144, 2015
522015
Silver Nanoparticles from Annona muricata Peel and Leaf Extracts as a Potential Potent, Biocompatible and Low Cost Antitumor Tool
MG González-Pedroza, L Argueta-Figueroa, R García-Contreras, ...
Nanomaterials 11 (5), 1273, 2021
272021
Anti-CD44-conjugated olive oil liquid nanocapsules for targeting pancreatic cancer stem cells
SA Navarro-Marchal, C Grinan-Lison, JM Entrena, G Ruiz-Alcalá, ...
Biomacromolecules 22 (4), 1374-1388, 2021
252021
A versatile theranostic nanodevice based on an orthogonal bioconjugation strategy for efficient targeted treatment and monitoring of triple negative breast cancer
MV Cano-Cortes, SA Navarro-Marchal, MP Ruiz-Blas, JJ Diaz-Mochon, ...
Nanomedicine: Nanotechnology, Biology and Medicine 24, 102120, 2020
252020
Albumin-covered lipid nanocapsules exhibit enhanced uptake performance by breast-tumor cells
F Galisteo-González, JA Molina-Bolívar, SA Navarro, H Boulaiz, ...
Colloids and Surfaces B: Biointerfaces 165, 103-110, 2018
252018
Biogeneration of silver nanoparticles from Cuphea procumbens for biomedical and environmental applications
MG González-Pedroza, ART Benítez, SA Navarro-Marchal, ...
Scientific Reports 13 (1), 790, 2023
202023
Lipid-core nanoparticles: Classification, preparation methods, routes of administration and recent advances in cancer treatment
P Graván, A Aguilera-Garrido, JA Marchal, SA Navarro-Marchal, ...
Advances in Colloid and Interface Science 314, 102871, 2023
192023
EZH2 endorses cell plasticity to non-small cell lung cancer cells facilitating mesenchymal to epithelial transition and tumour colonization
A Gallardo, A Molina, HG Asenjo, L Lopez-Onieva, J Martorell-Marugán, ...
Oncogene 41 (28), 3611-3624, 2022
92022
Antitumoral activity of 1, 2-diaminocyclohexane derivatives in breast, colon and skin human cancer cells
F Morales, A Ramírez, C Morata-Tarifa, SA Navarro, JA Marchal, ...
Future Medicinal Chemistry 9 (3), 293-302, 2017
92017
Silver Nanoparticles from Annona muricata Peel and Leaf Extracts as a Potential Potent, Biocompatible and Low Cost Antitumor Tool
SA Navarro Marchal, MG González Pedroza, Y Jiménez Martínez, ...
MDPI, 2021
52021
Maslinic acid solid lipid nanoparticles as hydrophobic anticancer drug carriers: Formulation, in vitro activity and in vivo biodistribution
A Aguilera-Garrido, P Graván, SA Navarro-Marchal, M Medina-O’Donnell, ...
Biomedicine & Pharmacotherapy 163, 114828, 2023
42023
1-(Benzenesulfonyl)-1, 5-dihydro-4, 1-benzoxazepine as a new scaffold for the design of antitumor compounds
O Cruz-López, A Ramírez, SA Navarro, MA García, JA Marchal, ...
Future Medicinal Chemistry 9 (11), 1129-1140, 2017
32017
Progress and hurdles of therapeutic nanosystems against cancer
M Martín-Contreras, SA Navarro-Marchal, JM Peula-García, ...
Pharmaceutics 14 (2), 388, 2022
22022
Development and evaluation of smart polymeric and lipidic nanoparticles for theranosis of breast and pancreatic cancer
SAN Marchal
Universidad de Granada, 2020
2*2020
First-in-class Transactivator-Free, Doxycycline-inducible IL-18-engineered CAR-T cells for relapsed/refractory B-cell lymphomas
PL Justicia-Lirio, M Tristan-Manzano, N Maldonado-Perez, ...
bioRxiv, 2024.01. 23.576842, 2024
2024
Effect of the Protein Corona Formation on Antibody Functionalized Liquid Lipid Nanocarriers
SA Navarro-Marchal, M Martín-Contreras, D Castro-Santiago, ...
International Journal of Molecular Sciences 24 (23), 16759, 2023
2023
In vivo studies demonstrate differences in target inhibition and anticancer efficacy between NXP900 and dasatinib in ovarian clear cell carcinoma model
S Navarro-Marchal, M Harvey, B King, RE Hughes, VG Brunton, ...
Cancer Research 83 (7_Supplement), 4031-4031, 2023
2023
Generation of first-in-class doxycycline-inducible IL-18 releasing CAR-T cells targeting solid tumors
P Justicia-Lirio, M Tristan-Manzano, N Maldonado-Perez, ...
HUMAN GENE THERAPY 33 (23-24), A14-A14, 2022
2022
Screening of NXP900 and dasatinib across 121 cancer cell lines identifies differences in their antiproliferative activity profiles
B King, RE Hughes, S Navarro-Marchal, VG Brunton, E Poradosu, ...
European Journal of Cancer 174, S113, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20